Shoshan Y, Gomori M, Moss L, Bari S, Edery N, Den R
J Neurooncol. 2025; .
PMID: 39747715
DOI: 10.1007/s11060-024-04919-5.
Levy O, Altaras A, Binyamini L, Sagi-Assif O, Izraely S, Cooks T
Cancers (Basel). 2024; 16(22).
PMID: 39594759
PMC: 11592378.
DOI: 10.3390/cancers16223804.
Sabri M, Moghaddasi L, Wilson P, Saran F, Bezak E
Target Oncol. 2024; 19(4):511-531.
PMID: 38836953
PMC: 11230998.
DOI: 10.1007/s11523-024-01071-y.
Nojima H, Kaida A, Matsuya Y, Uo M, Yoshimura R, Arazi L
Sci Rep. 2024; 14(1):11468.
PMID: 38769339
PMC: 11106084.
DOI: 10.1038/s41598-024-62071-6.
Skalina K, Malachowska B, Sindhu K, Thompson M, Nehlsen A, Salgado L
BJUI Compass. 2024; 5(3):334-344.
PMID: 38481668
PMC: 10927934.
DOI: 10.1002/bco2.316.
Bronchoscopic deployment and implantation of Diffusing alpha-emitters Radiation Therapy into the lung and mediastinum for treatment of lung cancer: a pre-clinical safety and feasibility study.
Sadoughi A, Sarkar A, Novotney C, Chan C, Moreno G, Oren S
Transl Lung Cancer Res. 2024; 13(1):60-75.
PMID: 38404993
PMC: 10891399.
DOI: 10.21037/tlcr-23-639.
Targeted Radium Alpha Therapy in the Era of Nanomedicine: In Vivo Results.
Trencsenyi G, Csikos C, Kepes Z
Int J Mol Sci. 2024; 25(1).
PMID: 38203834
PMC: 10779852.
DOI: 10.3390/ijms25010664.
Theranostic Imaging Surrogates for Targeted Alpha Therapy: Progress in Production, Purification, and Applications.
Nelson B, Wilson J, Andersson J, Wuest F
Pharmaceuticals (Basel). 2023; 16(11).
PMID: 38004486
PMC: 10674391.
DOI: 10.3390/ph16111622.
The Curies' element: state of the art and perspectives on the use of radium in nuclear medicine.
Franchi S, Asti M, Di Marco V, Tosato M
EJNMMI Radiopharm Chem. 2023; 8(1):38.
PMID: 37947909
PMC: 10638329.
DOI: 10.1186/s41181-023-00220-4.
Diffusing alpha-emitters radiation therapy in combination with temozolomide or bevacizumab in human glioblastoma multiforme xenografts.
Nishri Y, Vatarescu M, Luz I, Epstein L, Dumancic M, Del Mare S
Front Oncol. 2022; 12:888100.
PMID: 36237307
PMC: 9552201.
DOI: 10.3389/fonc.2022.888100.
Radon-220 diffusion from 224Ra-labeled calcium carbonate microparticles: Some implications for radiotherapeutic use.
Napoli E, Bonsdorff T, Jorstad I, Bruland O, Larsen R, Westrom S
PLoS One. 2021; 16(3):e0248133.
PMID: 33662039
PMC: 7932545.
DOI: 10.1371/journal.pone.0248133.
The Potentiation of Anti-Tumor Immunity by Tumor Abolition with Alpha Particles, Protons, or Carbon Ion Radiation and Its Enforcement by Combination with Immunoadjuvants or Inhibitors of Immune Suppressor Cells and Checkpoint Molecules.
Keisari Y, Kelson I
Cells. 2021; 10(2).
PMID: 33503958
PMC: 7912488.
DOI: 10.3390/cells10020228.
Targeted Alpha Therapy: Progress in Radionuclide Production, Radiochemistry, and Applications.
Nelson B, Andersson J, Wuest F
Pharmaceutics. 2021; 13(1).
PMID: 33396374
PMC: 7824049.
DOI: 10.3390/pharmaceutics13010049.
Recent Insights in Barium-131 as a Diagnostic Match for Radium-223: Cyclotron Production, Separation, Radiolabeling, and Imaging.
Reissig F, Bauer D, Ullrich M, Kreller M, Pietzsch J, Mamat C
Pharmaceuticals (Basel). 2020; 13(10).
PMID: 32992909
PMC: 7599757.
DOI: 10.3390/ph13100272.
RIG-1-Like Receptor Activation Synergizes With Intratumoral Alpha Radiation to Induce Pancreatic Tumor Rejection, Triple-Negative Breast Metastases Clearance, and Antitumor Immune Memory in Mice.
Domankevich V, Efrati M, Schmidt M, Glikson E, Mansour F, Shai A
Front Oncol. 2020; 10:990.
PMID: 32766128
PMC: 7379859.
DOI: 10.3389/fonc.2020.00990.
Clinical evidence of abscopal effect in cutaneous squamous cell carcinoma treated with diffusing alpha emitters radiation therapy: a case report.
Bellia S, Feliciani G, Del Duca M, Monti M, Turri V, Sarnelli A
J Contemp Brachytherapy. 2019; 11(5):449-457.
PMID: 31749854
PMC: 6854861.
DOI: 10.5114/jcb.2019.88138.
Combining alpha radiation-based brachytherapy with immunomodulators promotes complete tumor regression in mice via tumor-specific long-term immune response.
Domankevich V, Cohen A, Efrati M, Schmidt M, Rammensee H, Nair S
Cancer Immunol Immunother. 2019; 68(12):1949-1958.
PMID: 31637474
PMC: 6877484.
DOI: 10.1007/s00262-019-02418-5.
Leveraging Bioorthogonal Click Chemistry to Improve Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma.
Poty S, Carter L, Mandleywala K, Membreno R, Abdel-Atti D, Ragupathi A
Clin Cancer Res. 2018; 25(2):868-880.
PMID: 30352909
PMC: 6343144.
DOI: 10.1158/1078-0432.CCR-18-1650.
α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies-Part 1.
Poty S, Francesconi L, McDevitt M, Morris M, Lewis J
J Nucl Med. 2018; 59(6):878-884.
PMID: 29545378
PMC: 6004557.
DOI: 10.2967/jnumed.116.186338.
Radiotherapy Controversies and Prospective in Head and Neck Cancer: A Literature-Based Critical Review.
De Felice F, Polimeni A, Valentini V, Brugnoletti O, Cassoni A, Greco A
Neoplasia. 2018; 20(3):227-232.
PMID: 29448084
PMC: 5849807.
DOI: 10.1016/j.neo.2018.01.002.